临床试验

Study of Zifibancimig in Participants With Neovascular Age-related Macular Degeneration

NCT：NCT04567303 · COMPLETED

NCT编号NCT04567303

状态COMPLETED

开始日期2020-10-28

完成时间2026-08-25

SponsorHoffmann-La Roche (INDUSTRY)

First posted2020-09-28

Last updated2026-09-14

简要摘要

This is a first in-human study to investigate the safety, tolerability and efficacy of zifibancimig administered through intravitreal (IVT) injections and via the port delivery (PD) implant in participants with neovascular age-related macular degeneration (nAMD).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态，请参阅官方记录。